-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Experience in international clinical research: the HIV Prevention Trials Network
Nirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah Donnell, Susan H Eshleman,Sten H ermund
Research Article: Clinical Investigation
-
Experience in international clinical research: the HIV Prevention Trials Network
Nirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah Donnell, Susan H Eshleman,Sten H ermund
Research Article: Clinical Investigation
-
Experience in international clinical research: the HIV Prevention Trials Network
Nirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah Donnell, Susan H Eshleman,Sten H ermund
Research Article: Clinical Investigation
-
Experience in international clinical research: the HIV Prevention Trials Network
Nirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah Donnell, Susan H Eshleman,Sten H ermund
Research Article: Clinical Investigation
-
Experience in international clinical research: the HIV Prevention Trials Network
Nirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah Donnell, Susan H Eshleman,Sten H ermund
Research Article: Clinical Investigation
-
Experience in international clinical research: the HIV Prevention Trials Network
Nirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah Donnell, Susan H Eshleman,Sten H ermund
Research Article: Clinical Investigation
-
Experience in international clinical research: the HIV Prevention Trials Network
Nirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah Donnell, Susan H Eshleman,Sten H ermund
Research Article: Clinical Investigation
-
Experience in international clinical research: the HIV Prevention Trials Network
Nirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah Donnell, Susan H Eshleman,Sten H ermund
Research Article: Clinical Investigation
-
PARP inhibition: opening up new horizons?
Florian Heitz, Andreas du Bois
Editorial: Clinical Investigation
-
PARP inhibition: opening up new horizons?
Florian Heitz, Andreas du Bois
Editorial: Clinical Investigation
-
PARP inhibition: opening up new horizons?
Florian Heitz, Andreas du Bois
Editorial: Clinical Investigation
-
PARP inhibition: opening up new horizons?
Florian Heitz, Andreas du Bois
Editorial: Clinical Investigation
-
PARP inhibition: opening up new horizons?
Florian Heitz, Andreas du Bois
Editorial: Clinical Investigation
-
PARP inhibition: opening up new horizons?
Florian Heitz, Andreas du Bois
Editorial: Clinical Investigation
-
PARP inhibition: opening up new horizons?
Florian Heitz, Andreas du Bois
Editorial: Clinical Investigation
-
PARP inhibition: opening up new horizons?
Florian Heitz, Andreas du Bois
Editorial: Clinical Investigation